| Symbol | BLCO |
|---|---|
| Name | BAUSCH + LOMB CORPORATION COMMON SHARES |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Ophthalmic Goods |
| Address | 520 APPLEWOOD CRESCENT, VAUGHAN, Ontario, L4K 4B4, Canada |
| Telephone | +1 905 695-7700 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. Additional info from NASDAQ: |
(30% Negative) BAUSCH + LOMB CORPORATION COMMON SHARES (BLCO) Reports Q2 2026 Financial Results
Read moreBausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook
Read moreStewart Andrew J. 🔴 sold 4.2K shares of Bausch & Lomb Corp (BLCO) at $15.82 Transaction Date: Apr 24, 2026 | Filing ID: 000058
Read moreBailey A Robert D 🔴 sold 15.8K shares of Bausch & Lomb Corp (BLCO) at $15.82 Transaction Date: Apr 24, 2026 | Filing ID: 000057
Read moreBausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration
Read moreBausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
Read moreNew Form ARS - Bausch & Lomb Corp <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001140361-26-014240 <b>Size:</b> 2 MB
Read moreBausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update
Read moreBausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
Read more